Dr. Sutardja is the co-founder and former-CEO of Marvell Technology. Under his stewardship, Marvell achieved remarkable profitability, marked by its successful IPO in 2000. Dr. Sutardja's transformative leadership catapulted Marvell into the echelons of top global semiconductor companies, generating billions annually in revenue. With an impressive portfolio boasting over 440 patents, Dr. Sutardja is recognized as a Fellow of the Institute of Electrical and Electronics Engineers (IEEE).
“We are thrilled to welcome Dr. Sutardja, a distinguished industry visionary, to our Board of Directors," said George Xereas, Co-founder and Chief Executive Officer of Stathera. “Dr. Sutardja’s vast experience building and scaling semiconductor companies brings invaluable insights to our journey. With his guidance, Stathera will accelerate the commercialization of its breakthrough DualModeTM silicon timing technology and establish itself as a frontrunner in the $9.8 billion timing market.”
Dr. Sutardja’s appointment rounds out the Stathera Board of Directors, which includes Dr. George Xereas (CEO & Co-founder), Charles Lespérance (BDC Capital), Dr. Terry Gilton (Celesta Capital), and Dr. Wan-Thai Hsu (Chairman of the Board).
“Stathera’s proprietary MEMS timing technology is poised to re-architect the entire $9.8 Billion electronics timing industry,” said Dr. Sutardja. “I am excited to be joining the Board of Directors and use my experience to help drive commercialization, scale, and position the company as a market leader.”
About Stathera:
Stathera is a fabless semiconductor company focused on providing cutting-edge MEMS-based timing solutions. With offices in Montreal, Toronto, and Boston, our team is re-architecting the traditional quartz-based timing industry by introducing state-of-the-art DualMode™ frequency technology. This breakthrough innovation is redefining what is possible in timing applications and synchronization, and has the potential to transform the entire $9.8 Billion electronics timing industry.
For more information, please visit www.stathera.com.